Companies: 10,795·Total market cap: $144.5T

ALK-Abelló A/S

ALK-Abelló A/S

AKABYOTCHealthcare

$90.00

+$0.00(+0.00%)

Market Cap$0

P/E Ratio—

52W High$90

52W Low$90

Avg Volume23

Open$90.00

Beta0.43

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

ALK-Abelló A/S（AKABY）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · AKABY · 截至 Jun 8, 2026

关键指标

EPS (TTM)$1.45Earnings history

PE Ratio (TTM)62.1×PE Ratio deep dive

Revenue (TTM)$4.2BFull revenue history

Dividend Yield0.17%Dividend history

Shares Outstanding219.4MShares outstanding history

Next EarningsTBAEarnings history

探索 ALK-Abelló A/S 数据

分析师预测—

营收$3.9B+12.17%

盈利EPS $1.00+809.09%

市盈率62.1×

财务快照

FY 2021Revenue$3.92B▲ +12.17% YoY

201920202021

FY 2021Net Income$219.0M▲ +776.00% YoY

201920202021

FY 2021EPS$1.00▲ +809.09% YoY

201920202021

TTM:Revenue: $4.23BNet Income: $318.0MEPS: $1.45View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

ALK-Abelló A/S

$90.00+0.00%$0 #2

$22.25+0.68%$5.1B #3

Alpine Immune Sciences, Inc.

$64.97+0.02%$4.5B #4

Arena Pharmaceuticals, Inc.

$99.99+0.00%$0 #5

Churchill Capital Corp XI

$10.29-0.00%$431.1M #6

Global Blood Therapeutics, Inc.

股票表现

1D+0.00%

1W+0.00%

1M+0.00%

3M+0.00%

YTD+0.00%

1Y+0.00%

5Y+8.43%

关于 ALK-Abelló A/S

CEOCarsten Hellmann

IPO DateSep 5, 2013

Employees2,566

CountryDK

Websitealk.net

ALK-Abelló A/S operates as a global leader in allergy solutions, serving markets across Europe, North America, and internationally. The company provides a diverse range of allergy immunotherapy (AIT) …

Biotechnology HealthcareOTCADRDK

关于股票概览与关键数据

ALK-Abelló A/S（AKABY）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 5, 2013 在 OTC 上市。截至最近交易日，AKABY 股价为 $90.00，市值约为 $0。过去12个月累计回报 +0.00%，年初至今回报 +0.00%。

2021 财年 ALK-Abelló A/S 营收 $3.9B。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，ALK-Abelló A/S（AKABY）股价为 $90.00，在 OTC 上市，52周区间为 $90.00 – $90.00。

AKABY 最新股价AKABY quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议